he was with the company for 2 years and was paid in stock for service for COO and director. As of Sept he had 83,648 shares worth $ 2,091. I wonder if Richard Royall will be next. He has been with the company for 4 1/2 years and had been paid in stock for his service. As of Sept he had 34,119 shares worth about $ 700.
(1) An amendment to the Company’s current articles of incorporation to effect one or a series of forward or reverse splits of the Company’s common stock only for the express purpose, if required, in connection with obtaining a listing on a national securities exchange. Such a stock split to permit a listing on a national securities exchange will be at a ratio of not less than 2 and not greater than 400 with the exact ratio to be set within such range in the discretion of the Board of Directors, without further approval or authorization of the Company’s shareholders, provided that the Board of Directors determines to effect the forward or reverse stock split and any amendments to the Company’s articles of incorporation are filed with the Nevada Secretary of State (if necessary) no later than October 1, 2014. Neither the (i) number of authorized shares or the par value of the shares of the Company’s common stock nor (ii) number of authorized, issued and outstanding, any associated conversion ratio of the shares of Series A Preferred Stock will be changed in connection with any such reverse split.
Definition of 'Return On Equity - ROE'
The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
ROE is expressed as a percentage and calculated as:
Return on Equity = Net Income/Shareholder's Equity
On November 21, 2013, TranSwitch Corporation (the "Company") filed a voluntary petition (the "Bankruptcy Filing") for relief under Chapter 7 of the United States Bankruptcy Code
Application Number P090012
Most Recent Protocol Version Approved 08/08/2012
Study Name PAS of MelaFind
Study Status Progress Inadequate
Study Progress Reason Subject enrollment milestones not met
General Study Protocol Parameters
Study Design Prospective Cohort Study
Study involve follow-up of premarket cohort (Y/N) No
Data Source New Data Collection
Comparison Group No Control
Analysis Type Analytical
Study Population Neonate: 1-28 days, Infant: 29 days-2 yrs, Child: 2-12 yrs, Adolescent: 13-18 yrs, Transit. Adolescent A (distinctively) : 18-21 yrs, Adult: 21
Detailed Study Protocol Parameters
Study Design Description Prospective observational Study: A single-arm study has one study group consisting of eligible lesions on
This is a multicenter, prospective, observational, single arm, post-approval study of MelaFind, which will enroll lesions that meet the labeled Indications for Use. Dermatologists¿ biopsy decisions before and after obtaining MelaFind results will be recorded. Biopsy specimens will undergo central dermatopathology review to determine whether the lesion is melanoma, high-grade, or another type of lesion. Patient follow-up will extend out to 24 months.
SIFY TECHNOLOGIES LIMITED
2013 Special Meeting of Shareholders
To be held on Monday, November 11, 2013 for holders of record as of Friday, October 4, 2013
Vote Cutoff Date: Monday, November 4, 2013
RESOLVED THAT THE AMALGAMATION OF SIFY SOFTWARE LIMITED, (SSL)/TRANSFEROR COMPANY NO.1 AND HERMIT PROJECTS PRIVATE LIMITED (HERMIT)/ TRANSFEROR COMPANY NO.2, THE TWO WHOLLY OWNED SUBSIDIARY COMPANIES, WITH SIFY TECHNOLOGIES LIMITED (SIFY)/TRANSFEREE COMPANY, THE HOLDING COMPANY, BE AND IS HEREBY APPROVED, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT.
The Definitive 14C enables the Digital Angel to effect a one for thirty reverse stock split, name change to VeriTeQ Corporation and stock symbol change, all of which has received the necessary Board and stockholder approvals, and is expected to occur on or around October 18, 2013.
Pay Dr. M. Ali Khatibzadeh , 52
Chief Exec. Officer, Pres, Director and Member of Exec. Committee 335.00K 0.00
Mr. Robert A. Bosi , 57
Chief Financial Officer, Principal Accounting Officer and VP 322.00K 0.00
Mr. Amir Bar-Niv , 48
Sr. VP and Gen. Mang. of High Speed Interconnect Bus. Unit 244.00K 0.00
Mr. Haim Moshe , 54
Sr. VP and Gen. Mang. of Transwitch Israel 299.00K 0.00
Oclaro falls into the SECs Accelerated Filer category – those that have at least $75 million, but less than $700 million, in public float - and are allowed 75 days to report financial results after the close of the fiscal year end.